Moreover, the molecular mechanisms of PUS1 involvement in melanoma and breast cancer, and PUS10 involvement in prostate cancer have also been initially explored (Zhao et al., 2004; Jana et al., 2017). Here, PUS1 is linked to prostate carcinoma.